The PINNACLE study: A multicentre phase II trial of nilotinib in combination with pegylated interferon-α2b in newly diagnosed chronic phase chronic myeloid leukaemia
Yeung DT et al. Br J Haematol, December 2025 (epub ahead of print)
Link to full abstract